Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001004595 | SCV001163758 | likely pathogenic | Tyrosinemia type I | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV001004595 | SCV001383319 | pathogenic | Tyrosinemia type I | 2023-07-31 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Trp242*) in the FAH gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FAH are known to be pathogenic (PMID: 9101289, 9633815). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with tyrosinemia, type 1 (PMID: 25681080). ClinVar contains an entry for this variant (Variation ID: 813490). |
Fulgent Genetics, |
RCV001004595 | SCV005635336 | likely pathogenic | Tyrosinemia type I | 2024-03-19 | criteria provided, single submitter | clinical testing |